Skip to main navigation

Hablamos Español

ketamine therapy


FDA Panel Recommends New Depression Treatment/THE NEW YORK TIMES FEB12/2019

ketamine nasal spray is in the process of being approved by the FDA a step forward in the direction of IV ketamine therapy, which many anesthesiologist, psychiatrist, and key witnesses have been trying to push forward . Developed by Johnson and Johnson Esketamine, was  presented to the FDA by consumer witnesses and  17 top psychiatrists, and it  was unanimously […]

Read More

Ketamine in the American Journal of Medicine Dec 2018

Ketamine is a dissociative anesthetic medication working on NMDA receptors in the brain and  mu opioid receptors in the spinal cord. Studies show that ketamine is an effective treatment for chronic and acute pain , working even more effectively than opioids.  It has been successfully used for pain relief and reduces the amount of opioid usage. There […]

Read More